| Long name | NR2F2 Primary Polyclonal Antibody |
| Also known as | NR2F2 PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | NR2F2 |
| Specificity | This is a highly specific antibody against NR2F2 |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human NR2F2 |
| Gene ID number | 7025 |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | It belongs to the nuclear hormone receptor family, It binds to DNA site A as a homodimer, It has roles in angiogenesis, NR2 subfamily, vascular remodeling and heart development, NR2F2 is involved in the regulation of the apolipoprotein A-I gene transcription |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | ARP1, COT1_HUMAN, COUP TF2, COUP transcription factor 1, COUP transcription factor 2, COUP transcription factor I, COUP-TF I, COUP-TF1, Chicken ovalbumin upstream promoter 1, EAR-3, EAR3, ERBAL3, NR2F1, NR2F2, Nuclear receptor subfamily 2 group F member 1, SVP44, TCFCOUP1, TFCOUP1, Transcription factor COUP 1, V ERBA related protein EAR 3, V-erbA-related protein 3, Apolipoprotein AI regulatory protein 1 |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | NR2F2 |
| Short name | NR2F2 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | family F, member 2 (Antibody to), nuclear receptor subfamily 2 |
| Alternative technique | antibodies |
| Alternative to gene target | ARP1 and CHTD4 and COUPTFB and COUPTFII and NF-E3 and NR2F1 and SVP40 and TFCOUP2, DNA-templated and biological process this GO :0006355 and regulation of transcription, DNA-templated and biological process this GO :0006357 and regulation of transcription from RNA polymerase II promoter and biological process this GO :0006629 and lipid metabolic process and biological process this GO :0007165 and signal transduction and biological process this GO :0007519 and skeletal muscle tissue development and biological process this GO :0008270 and zinc ion binding and molecular function this GO :0009566 and fertilization and biological process this GO :0009952 and anterior/posterior pattern specification and biological process this GO :0009956 and radial pattern formation and biological process this GO :0010596 and negative regulation of endothelial cell migration and biological process this GO :0030522 and intracellular receptor signaling pathway and biological process this GO :0030900 and forebrain development and biological process this GO :0032355 and response to estradiol and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0043401 and steroid hormone mediated signaling pathway and biological process this GO :0043565 and sequence-specific DNA binding and molecular function this GO :0045736 and negative regulation of cyclin-dependent protein serine/threonine kinase activity and biological process this GO :0045892 and negative regulation of transcription, DNA-templated and biological process this GO :0045893 and positive regulation of transcription, DNA-templated and biological process this GO :0048514 and blood vessel morphogenesis and biological process this GO :0060173 and limb development and biological process this GO :0060674 and placenta blood vessel development and biological process this GO :0060707 and trophoblast giant cell differentiation and biological process this GO :0060849 and regulation of transcription involved in lymphatic endothelial cell fate commitment and biological process, NR2F2 and IDBG-31309 and ENSG00000185551 and 7026, NR2F2 and IDBG-628692 and ENSBTAG00000018007 and 281945, Nr2f2 and IDBG-192528 and ENSMUSG00000030551 and 11819, group F, member 2, nuclei, sequence-specific DNA binding, this GO :0000122 and negative regulation of transcription from RNA polymerase II promoter and biological process this GO :0001701 and in utero embryonic development and biological process this GO :0001764 and neuron migration and biological process this GO :0001893 and maternal placenta development and biological process this GO :0001937 and negative regulation of endothelial cell proliferation and biological process this GO :0001945 and lymph vessel development and biological process this GO :0001972 and retinoic acid binding and molecular function this GO :0003677 and DNA binding and molecular function this GO :0003700 and sequence-specific DNA binding transcription factor activity and molecular function this GO :0003707 and steroid hormone receptor activity and molecular function this GO :0003714 and transcription corepressor activity and molecular function this GO :0004879 and ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0006351 and transcription, this GO :0001972: retinoic acid binding, this GO :0001972: retinoic acid binding and also this GO :0003677: DNA binding and also this GO :0003700: sequence-specific DNA binding transcription factor activity and also this GO :0003707: steroid hormone receptor activity and also this GO :0003714: transcription corepressor activity and also this GO :0004879: ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity and also this GO :0005515: protein binding and also this GO :0008270: zinc ion binding and also this GO :0042803: protein homodimerization activity and also this GO :0043565: sequence-specific DNA binding, this GO :0003677: DNA binding, this GO :0003700: sequence-specific DNA binding transcription factor activity, this GO :0003707: steroid hormone receptor activity, this GO :0003714: transcription corepressor activity, this GO :0004879: ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity, this GO :0005515: protein binding, this GO :0008270: zinc ion binding, this GO :0042803: protein homodimerization activity, this GO :0043565: sequence-specific DNA binding, nuclear receptor subfamily 2 |
| Identity | 7976 |
| Gene | NR2F2 |
| Long gene name | nuclear receptor subfamily 2 group F member 2 |
| Synonyms gene | ARP1 TFCOUP2 |
| Synonyms gene name | group F, member 2 , nuclear receptor subfamily 2 |
| Synonyms | COUP-TFII COUPTFB SVP40 NF-E3 |
| Locus | 15q26, 2 |
| Discovery year | 1995-03-21 |
| GenBank acession | M64497 |
| Entrez gene record | 7026 |
| Pubmed identfication | 8530078 11544252 |
| Classification | Nuclear hormone receptors |
| Havana BLAST/BLAT | OTTHUMG00000149848 |
Technique
Supplier
Species
Label
Iso Type
Host
Tissue